Skip to main content

Ali Ataya, MD : Research

Critical Care Medicine Specialist, Pulmonologist (Lung Specialist)

Rated 4.9 out of 5 stars
33 ratings 4 reviews
Photo of Ali Ataya
(352) 273-8740 MyUFHealth

Research at a glance

Top areas of exploration

  • Dyspnea , 7 publications
  • Hypertension, Pulmonary , 4 publications
  • Pleural Effusion , 4 publications
  • Disease Progression , 3 publications

Research activity

87 publications

287 citations

Why is this important?

Active clinical trials

Prosera

The primary objective of the study is to determine the effect of seralutinib on improving exercise capacity in subjects with WHO Group 1 PAH who are FC II or III. The secondary objective for this trial is to determine time to clinical worsening.

Investigator
Ali Ataya
Status
Accepting Candidates
Ages
18 Years - 75 Years
Sexes
All
Hemotag
Investigator
Ali Ataya
Status
Accepting Candidates
ROR-PH-303 (APD811-303)

Study ROR-PH-303, ADVANCE EXTENSION, is an open-label extension (OLE) study for participants with WHO Group 1 PAH who have participated in another Phase 2 or Phase 3 study of ralinepag.

Investigator
Ali Ataya
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All

My publications

87 publications

2026

BMPR2 Splice‐Site Variant in a Patient With Pulmonary Arteriovenous Malformation and Delayed‐Onset Pulmonary Arterial Hypertension: A Case Report and Mechanistic Phenocopy Hypothesis

American Journal of Medical Genetics Part A

Publisher's site

2026

Pulmonary hypertension associated with hereditary haemorrhagic telangiectasia: from genetics to clinical management

European Respiratory Journal

Publisher's site

2025

Sirolimus Use During Pregnancy in Women with Lymphangioleiomyomatosis

Annals of the American Thoracic Society

Publisher's site